[Form 4] Alignment Healthcare, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Robert L. Scavo, Chief Information Officer and director of Alignment Healthcare, Inc. (ALHC), sold shares on 09/10/2025 to satisfy tax withholding from RSU vesting. The filing reports two non-discretionary sales: 21,123 shares at a weighted-average price of $16.2293 (individual trade prices ranged $15.74 to $16.735) and 8,412 shares at a weighted-average price of $16.8555 (individual trade prices ranged $16.74 to $17.24). After these transactions he beneficially owned 580,967 shares following the first set and 572,555 shares following the second set, held directly. The sales were executed pursuant to tax-withholding obligations and were not discretionary trades.

Positive

• Clear disclosure that the sales were to satisfy tax withholding on RSU vesting, not discretionary trades
• Reporting shows substantial retained ownership (580,967 and 572,555 shares after transactions)
• Provides weighted-average prices and price ranges and offers to supply detailed per-trade information on request

Negative

• Insider ownership decreased due to sales to cover tax withholding
• Filing does not specify exact per-trade share counts at each price; only weighted-average and ranges are provided

Insights

Securities Analyst

TL;DR: Routine RSU withholding sales by an insider; disclosure is complete and non-discretionary, so limited material impact on valuation.

The reported transactions are standard tax-withholding sales tied to RSU vesting rather than open-market, discretionary liquidations. The filing provides weighted-average prices and ranges for the trades and shows substantial remaining direct ownership (over 570,000 shares), suggesting continuing insider alignment with shareholders. For investors, these transactions should be viewed as administrative rather than signals of changed insider confidence.

Corporate Governance Expert

TL;DR: Compliance-focused filing that documents required insider share disposition to cover taxes; governance and reporting appear appropriate.

The form clearly identifies the reporting person as CIO and director and explains the sales were to cover tax withholding for vested RSUs. The signer is an attorney-in-fact and the filing includes price ranges and an offer to provide detailed breakdowns on request, reflecting transparent reporting. There is no indication of regulatory or governance issues from this disclosure alone.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Scavo Robert L.

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Information Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/10/2025		S		21,123(1)	D	$16.2293(2)	580,967	D
Common Stock	09/10/2025		S		8,412(1)	D	$16.8555(3)	572,555	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.74 to $16.735. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

3. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.74 to $17.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Robert L. Scavo	09/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Why did Robert L. Scavo sell shares on 09/10/2025 (ALHC)?

The filing states the sales were to cover tax withholding obligations arising from the vesting of restricted stock units; they were not discretionary trades.

How many ALHC shares did the insider sell and what were the prices?

The filing reports sales of 21,123 shares at a weighted-average price of $16.2293 (range $15.74 to $16.735) and 8,412 shares at a weighted-average price of $16.8555 (range $16.74 to $17.24).

How many ALHC shares does Robert L. Scavo beneficially own after the transactions?

The filing shows beneficial ownership of 580,967 shares after the first reported sale and 572,555 shares after the second reported sale, held directly.

What is Robert L. Scavo's role at Alignment Healthcare (ALHC)?

The filing identifies him as a Director and Chief Information Officer (Officer) of Alignment Healthcare, Inc.

Does the filing indicate any discretionary insider selling or trading plan?

No. The filing explicitly explains the transactions represent sales to cover tax withholding for RSU vesting and states they do not represent discretionary trades.